- Home
- HHH vs LGND Comparison
HHH vs LGND Comparison
Compare HHH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HHH | LGND |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | HHH | LGND |
|---|---|---|
| Price | $66.00 | $231.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $90.00 | ★ $247.29 |
| AVG Volume (30 Days) | ★ 378.2K | 200.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.21 | N/A |
| Revenue | ★ $1,474,892,000.00 | N/A |
| Revenue This Year | $14.04 | $1.61 |
| Revenue Next Year | N/A | $18.93 |
| P/E Ratio | ★ $29.28 | $76.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $61.01 | $98.90 |
| 52 Week High | $91.07 | $234.76 |
Technical Indicators
Market Signals| Indicator | HHH | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 67.12 |
| Support Level | $61.54 | $180.85 |
| Resistance Level | $71.20 | N/A |
| Average True Range (ATR) | 1.46 | 8.53 |
| MACD | 0.74 | 2.83 |
| Stochastic Oscillator | 82.65 | 92.72 |
Price Performance
Historical ComparisonAbout HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.